CHEK2
Top View
- The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
- 3-Phosphoinositide-Dependent Protein Kinase-1 As an Emerging Target in the Management of Breast Cancer
- Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
- Associations Between Mutations of the Cell Cycle Checkpoint Kinase 2 Gene and Gastric Carcinogenesis
- List of Actionable Genes and Potential Matched Therapy
- Cancer Susceptibility Mutations in Patients with Urothelial Malignancies the Following Represents Disclosure Information Provided by Authors of This Manuscript
- A Resource for Exploring the Understudied Human Kinome for Research and Therapeutic
- Germline and Somatic NF1 Alterations Are Linked to Increased HER2 Expression in Breast Cancer Xia Wang1, Roope A
- CHEK2 Gene Mutation Analysis Assay Summary
- Transposon Insertional Mutagenesis in Mice Identifies Human Breast Cancer Susceptibility Genes and Signatures for Stratification
- CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather Than Checkmate
- Prevalence of Germline Mutations in Cancer Susceptibility Genes In
- Absence of EIF1AX, PPM1D, and CHEK2 Mutations Reported in Thyroid Cancer Genome Atlas (TCGA) in a Large Series of Thyroid Cancer
- CHEK2 Clinical Guide
- CHEK2 Pathogenic Variants in Greek Breast Cancer Patients
- Early Colorectal Cancers Provide New Evidence for a Lynch Syndrome-To-CMMRD Phenotypic Continuum
- Realtime Ready Plate Layout Human Cell Cycle Regulation Panel, 96
- Findings from the Breast Cancer Association Consortium Taru A